Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc.（VNDA）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · VNDA · 截至 2026年6月8日
活动摘要
买入笔数
4
P-Purchase only
卖出笔数
7
近12个月
买卖比
0.57
Buy/Sell (by trades)
整体情绪
Vanda Pharmaceuticals Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
VNDA 季度内部人买卖趋势
VNDA 内幕交易卖出 · VNDA 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · VNDA CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
VNDA 高管卖出股份 · VNDA 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| May 18, 2026 | Mitchell Stephen Ray Director | Gift | 25,836 | — | Form 4 |
| Apr 22, 2026 | Duncan Charles Cliff Director | Award | 57,101 | — | Form 4 |
| Mar 2, 2026 | Williams Timothy SVP & General Counsel | Sale | 42,434 | $351K | Form 4 |
| Mar 2, 2026 | Moran Kevin Patrick SVP, CFO & Treasurer | Sale | 42,442 | $351K | Form 4 |
| Mar 2, 2026 | Wijkstrom Joakim SVP, Chief Marketing Officer | Sale | 30,800 | $255K | Form 4 |
| Mar 2, 2026 | Polymeropoulos Mihael Hristos Director | Sale | 156,235 | $1.28M⚡ | Form 4 |
| Mar 2, 2026 | Birznieks Gunther SVP, Business Development | Sale | 42,431 | $351K | Form 4 |
| Feb 23, 2026 | Honore Tage Director | Sale | 30,000 | $241K | Form 4 |
| Feb 18, 2026 | Wijkstrom Joakim SVP, Chief Marketing Officer | Award | 125,000 | — | Form 4 |
| Feb 18, 2026 | Birznieks Gunther SVP, Business Development | Award | 125,000 | — | Form 4 |
| Feb 18, 2026 | Williams Timothy SVP & General Counsel | Award | 125,000 | — | Form 4 |
| Feb 18, 2026 | Moran Kevin Patrick SVP, CFO & Treasurer | Award | 125,000 | — | Form 4 |
| Feb 18, 2026 | Polymeropoulos Mihael Hristos Director | Award | 525,000 | — | Form 4 |
| Aug 7, 2025 | Polymeropoulos Mihael Hristos Director | Purchase | 10,000 | $42K | Form 4 |
| Jun 13, 2025 | Mitchell Stephen Ray Director | Sale | 7,000 | $32K | Form 4 |
| Jun 5, 2025 | Mitchell Stephen Ray Director | Award | 59,225 | — | Form 4 |
| Jun 5, 2025 | Chrousos Phaedra Director | Award | 59,225 | — | Form 4 |
| Jun 5, 2025 | DUGAN RICHARD W Director | Award | 59,225 | — | Form 4 |
| Jun 5, 2025 | Honore Tage Director | Award | 59,225 | — | Form 4 |
| Jun 5, 2025 | Ward Anne Sempowski Director | Award | 59,225 | — | Form 4 |
| May 21, 2025 | Polymeropoulos Mihael Hristos Director | Purchase | 481 | $2K | Form 4 |
| May 21, 2025 | Polymeropoulos Mihael Hristos Director | Purchase | 9,519 | $42K | Form 4 |
| May 16, 2025 | Polymeropoulos Mihael Hristos Director | Purchase | 20,000 | $84K | Form 4 |
| Mar 6, 2025 | Polymeropoulos Mihael Hristos Director | Purchase | 5,000 | $25K | Form 4 |
| Mar 6, 2025 | Polymeropoulos Mihael Hristos Director | Purchase | 5,000 | $25K | Form 4 |
Wijkstrom Joakim
SVP, Chief Marketing Officer
日期
Mar 2
股数
30,800
均价
$8.27
总金额
$255K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 VNDA 内幕交易
VNDA 内幕交易
Vanda Pharmaceuticals Inc.（VNDA）内幕交易数据来源于公司内部人（包括Polymeropoulos Mihael Hristos (Director), Mitchell Stephen Ray (Director), Williams Timothy (SVP & General Counsel)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。VNDA内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Vanda Pharmaceuticals Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
VNDA 内幕交易 · 5个问题Vanda Pharmaceuticals Inc.（VNDA）的内部人包括高管和董事，如Polymeropoulos Mihael Hristos (Director), Mitchell Stephen Ray (Director), Williams Timothy (SVP & General Counsel)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026